Please login to the form below

Not currently logged in

Icon appoints Allergan’s Ira Spector

He also has 17 years’ experience at Wyeth
icon ira spector

Dr Ira Spector has left his senior role at Allergan to join the clinical research organisation (CRO) Icon as executive VP, analytics and consulting.

Dr Spector was most recently senior VP of global development operations at Allergan where he spent four years. Prior to this he spent 17 years at Wyeth, leaving shortly after the company's takeover by Pfizer.

In his new role at Icon Dr Spector will lead the company's global consulting and drug development services and will also be responsible for Icon's business process improvement and analytics capabilities.

Icon's chief operating officer Dr Steve Cutler commented on the new appointment: “His extensive experience in managing some of the world's largest trials in areas such as oncology, vaccines and CNS, coupled with his expertise in using technology to drive innovation and process improvement, will enable us to provide further strategic input to our customers' drug and device programmes.”

10th September 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....